Panagiotis A. Konstantinopoulos

机构：Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center · ORCID：0000-0002-1032-1479

发表论文 484 篇 · 总被引 19948 次 · h-index 67

代表论文

• Niraparib and dostarlimab for the treatment of recurrent platinum-resistant ovarian cancer: results of a Phase II study (MOONSTONE/GOG-3032) (2023 · Gynecologic Oncology · 被引 29)
• Dynamics of the DYNLL1–MRE11 complex regulate DNA end resection and recruitment of Shieldin to DSBs (2023 · Nature Structural & Molecular Biology · 被引 29)
• Randomized Phase II Study of Gemcitabine With or Without ATR Inhibitor Berzosertib in Platinum-Resistant Ovarian Cancer: Final Overall Survival and Biomarker Analyses (2024 · JCO Precision Oncology · 被引 22)
• 53BP1 loss elicits cGAS-STING-dependent antitumor immunity in ovarian and pancreatic cancer (2024 · Nature Communications · 被引 19)
• Abstract CT008: A phase 2, two-stage study of mirvetuximab soravtansine (IMGN853) in combination with pembrolizumab in patients with microsatellite stable (MSS) recurrent or persistent endometrial cancer (2024 · Cancer Research · 被引 16)
• Feasibility and acceptability of a nurse-led telehealth intervention (BOLSTER) to support patients with peritoneal carcinomatosis and their caregivers: A pilot randomized clinical trial (2024 · Gynecologic Oncology · 被引 12)